Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation ...
VITL, the operating system for cash-pay health, announced the close of its $7.5 million Series A funding round led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results